ConforNets: Latents-Based Conformational Control in OpenFold3
Abstract
Models from the AlphaFold (AF) family reliably predict one dominant conformation for most well-ordered proteins but struggle to capture biologically relevant alternate states. Several efforts have focused on eliciting greater conformational variability through ad hoc inference-time perturbations of AF models or their inputs. Despite their progress, these approaches remain inefficient and fail to consistently recover major conformational modes. Here, we investigate both the optimal location and m...
Description / Details
Models from the AlphaFold (AF) family reliably predict one dominant conformation for most well-ordered proteins but struggle to capture biologically relevant alternate states. Several efforts have focused on eliciting greater conformational variability through ad hoc inference-time perturbations of AF models or their inputs. Despite their progress, these approaches remain inefficient and fail to consistently recover major conformational modes. Here, we investigate both the optimal location and manner-of-operation for perturbing latent representations in the AF3 architecture. We distill our findings in ConforNets: channel-wise affine transforms of the pre-Pairformer pair latents. Unlike previous methods, ConforNets globally modulate AF3 representations, making them reusable across proteins. On unsupervised generation of alternate states, ConforNets achieve state-of-the-art success rates on all existing multi-state benchmarks. On the novel supervised task of conformational transfer, ConforNets trained on one source protein can induce a conserved conformational change across a protein family. Collectively, these results introduce a mechanism for conformational control in AF3-based models.
Source: arXiv:2604.18559v1 - http://arxiv.org/abs/2604.18559v1 PDF: https://arxiv.org/pdf/2604.18559v1 Original Link: http://arxiv.org/abs/2604.18559v1
Please sign in to join the discussion.
No comments yet. Be the first to share your thoughts!
Apr 21, 2026
Pharmaceutical Research
Biochemistry
0